JP4276838B2 - 疼痛(pain)の治療における使用のためのカルバメート化合物 - Google Patents

疼痛(pain)の治療における使用のためのカルバメート化合物 Download PDF

Info

Publication number
JP4276838B2
JP4276838B2 JP2002567289A JP2002567289A JP4276838B2 JP 4276838 B2 JP4276838 B2 JP 4276838B2 JP 2002567289 A JP2002567289 A JP 2002567289A JP 2002567289 A JP2002567289 A JP 2002567289A JP 4276838 B2 JP4276838 B2 JP 4276838B2
Authority
JP
Japan
Prior art keywords
pain
formula
group
composition
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002567289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004523553A (ja
JP2004523553A5 (cg-RX-API-DMAC10.html
Inventor
プラタ−サラマン,カルロス・アール
ツアオ,ボユ
ツインマン,ロイ・イー
Original Assignee
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド filed Critical オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド
Publication of JP2004523553A publication Critical patent/JP2004523553A/ja
Publication of JP2004523553A5 publication Critical patent/JP2004523553A5/ja
Application granted granted Critical
Publication of JP4276838B2 publication Critical patent/JP4276838B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2002567289A 2001-02-27 2002-02-21 疼痛(pain)の治療における使用のためのカルバメート化合物 Expired - Fee Related JP4276838B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
PCT/US2002/005421 WO2002067922A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (3)

Publication Number Publication Date
JP2004523553A JP2004523553A (ja) 2004-08-05
JP2004523553A5 JP2004523553A5 (cg-RX-API-DMAC10.html) 2005-12-22
JP4276838B2 true JP4276838B2 (ja) 2009-06-10

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567289A Expired - Fee Related JP4276838B2 (ja) 2001-02-27 2002-02-21 疼痛(pain)の治療における使用のためのカルバメート化合物

Country Status (28)

Country Link
US (1) US6815464B2 (cg-RX-API-DMAC10.html)
EP (1) EP1404312B1 (cg-RX-API-DMAC10.html)
JP (1) JP4276838B2 (cg-RX-API-DMAC10.html)
KR (1) KR100906315B1 (cg-RX-API-DMAC10.html)
CN (1) CN1849116A (cg-RX-API-DMAC10.html)
AR (1) AR033427A1 (cg-RX-API-DMAC10.html)
AT (1) ATE493125T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002254015B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207673A (cg-RX-API-DMAC10.html)
CA (1) CA2439274C (cg-RX-API-DMAC10.html)
CY (1) CY1111349T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20032298A3 (cg-RX-API-DMAC10.html)
DE (1) DE60238765D1 (cg-RX-API-DMAC10.html)
DK (1) DK1404312T3 (cg-RX-API-DMAC10.html)
ES (1) ES2356617T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0303236A3 (cg-RX-API-DMAC10.html)
IL (1) IL157593A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03007721A (cg-RX-API-DMAC10.html)
MY (1) MY129312A (cg-RX-API-DMAC10.html)
NO (1) NO20033804L (cg-RX-API-DMAC10.html)
NZ (1) NZ527994A (cg-RX-API-DMAC10.html)
PL (1) PL364647A1 (cg-RX-API-DMAC10.html)
PT (1) PT1404312E (cg-RX-API-DMAC10.html)
RS (1) RS67603A (cg-RX-API-DMAC10.html)
RU (1) RU2283106C2 (cg-RX-API-DMAC10.html)
TW (1) TWI304735B (cg-RX-API-DMAC10.html)
WO (1) WO2002067922A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200307475B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007934A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
RU2632659C2 (ru) * 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
ATE226071T1 (de) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc Antikonvulsive derivate zur behandlung von neuropathischem schmerz
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PL365701A1 (en) 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
KR100906315B1 (ko) 2009-07-07
JP2004523553A (ja) 2004-08-05
CZ20032298A3 (cs) 2004-08-18
AU2002254015B2 (en) 2006-08-24
ATE493125T1 (de) 2011-01-15
NO20033804L (no) 2003-09-30
RU2003128984A (ru) 2005-03-20
CA2439274C (en) 2011-04-05
WO2002067922A1 (en) 2002-09-06
PL364647A1 (en) 2004-12-13
TWI304735B (en) 2009-01-01
MXPA03007721A (es) 2004-11-12
KR20030076711A (ko) 2003-09-26
RU2283106C2 (ru) 2006-09-10
CA2439274A1 (en) 2002-09-06
NO20033804D0 (no) 2003-08-26
CY1111349T1 (el) 2015-08-05
EP1404312A1 (en) 2004-04-07
NZ527994A (en) 2005-11-25
US20020156127A1 (en) 2002-10-24
US6815464B2 (en) 2004-11-09
RS67603A (sr) 2007-02-05
MY129312A (en) 2007-03-30
EP1404312B1 (en) 2010-12-29
IL157593A0 (en) 2004-03-28
DK1404312T3 (da) 2011-03-14
AR033427A1 (es) 2003-12-17
DE60238765D1 (de) 2011-02-10
ZA200307475B (en) 2005-01-03
HUP0303236A3 (en) 2012-07-30
BR0207673A (pt) 2004-12-28
CN1849116A (zh) 2006-10-18
ES2356617T3 (es) 2011-04-11
PT1404312E (pt) 2011-02-01
HUP0303236A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
KR101785072B1 (ko) 하지 불안 증후군의 치료방법
ES2435403T3 (es) Tratamiento de trastornos del sueño y vigilia
CA2439274C (en) Carbamate compounds for use in the treatment of pain
AU2002254015A1 (en) Carbamate compounds for use in the treatment of pain
JP4276839B2 (ja) 双極性障害の予防もしくは治療における使用のためのカルバメート化合物
RS50676B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
JP4276837B2 (ja) 双極性障害の予防もしくは治療における使用のためのカルバメート化合物
RU2292881C2 (ru) Соединения карбамата для применения при профилактике или лечении тревожных расстройств
JP5271473B2 (ja) 神経障害性疼痛ならびに群発性頭痛および偏頭痛に関連する疼痛の予防もしくは治療における使用のためのカルバメート化合物
ES2327721T3 (es) Compuestos de carbamato para uso en la prevencion o tratamiento del dolor neuropatico.
JP4362368B2 (ja) 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物
HK1062270B (en) Carbamate compounds for use in preventing or treating anxiety disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041224

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080427

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080715

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080912

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080922

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090109

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090303

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090309

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120313

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees